Instructions for Anaferon tablets No. 20
Composition
active ingredient: 1 tablet contains affinity purified antibodies to human gamma interferon: a mixture of homeopathic dilutions C12, C30 and C200 – 3 mg;
excipients: lactose monohydrate, microcrystalline cellulose, magnesium stearate.
Dosage form
Pills.
Main physicochemical properties: flat-cylindrical tablets, with a score and a bevel, white to almost white in color. One flat side has a score, the other flat side has the inscription ANAFERON.
Pharmacotherapeutic group
Homeopathic medicine.
Pharmacological properties
The drug is used for the treatment and prevention of acute respiratory viral infections and influenza. In prophylactic and therapeutic use, it has an antiviral effect. Experimentally and clinically proven efficacy against influenza viruses, parainfluenza, herpes simplex viruses 1 and 2 types (labial herpes, genital herpes), other herpesviruses (chickenpox, infectious mononucleosis), enteroviruses, tick-borne encephalitis virus, rotavirus, coronavirus, calicivirus, adenovirus, respiratory syncytial virus (RS-virus). The drug reduces the concentration of the virus in the affected tissues, acts on the system of endogenous interferons and related cytokines, induces the formation of endogenous "early" interferons (IFN α/β) and γ-interferon (γ-IFN). It has antimutagenic properties.
Indication
Prevention and treatment of acute respiratory viral infections (including influenza).
Complex therapy of infections caused by herpesviruses (infectious mononucleosis, chickenpox, labial herpes, genital herpes).
Comprehensive therapy and prevention of relapses of chronic herpesvirus infection, including labial and genital herpes.
Complex therapy and prevention of other acute and chronic viral infections caused by tick-borne encephalitis virus, enterovirus, rotavirus, coronavirus, calicivirus.
Comprehensive therapy of secondary immunodeficiency states of various etiologies, including prevention and treatment of complications of viral and bacterial infections.
Contraindication
Increased individual sensitivity to the components of the drug.
Interaction with other medicinal products and other types of interactions
No cases of incompatibility with other drugs have been registered.
If necessary, the drug can be used in combination with other antiviral, antibacterial and symptomatic agents.
Application features
The medicinal product contains lactose monohydrate, therefore it is not recommended for use in patients with congenital galactosemia, glucose malabsorption syndrome or congenital lactase deficiency.
Use during pregnancy or breastfeeding
There is no data on the efficacy and safety of the drug during pregnancy or breastfeeding, so it should not be prescribed during these periods.
Ability to influence reaction speed when driving vehicles or other mechanisms
Does not affect the reaction speed when driving or working with other mechanisms.
Method of administration and doses
The drug is taken orally, 1 tablet 30 minutes before or 30 minutes after a meal. The tablet is kept in the mouth (preferably without chewing or swallowing) until completely dissolved.
SARS, influenza, intestinal infections, herpesvirus infections, neuroinfections.
Treatment should be started as early as possible at the first signs of an acute viral infection according to the following scheme: for the first 2 hours, the drug is taken every 30 minutes (5 doses), then during the first day - another 3 tablets at regular intervals (a total of 8 tablets during the first day). Starting from the 2nd day onwards, the drug is taken 1 tablet 3 times a day until complete recovery.
If there is no improvement on the third day of treatment with the drug for acute respiratory viral infections and influenza, you should consult a doctor.
For prevention, take 1 tablet once a day every day for 1–3 months (during the entire epidemic season).
Genital herpes. In acute manifestations of genital herpes, it is taken at regular intervals according to the following scheme: 1–3 days – 1 tablet 8 times a day, then – 1 tablet 4 times a day for at least 3 weeks.
For the prevention of relapses of chronic herpesvirus infection - 1 tablet per day. The recommended duration of the preventive course is determined individually and can reach 6 months.
For the treatment and prevention of immunodeficiency states, take 1 tablet per day.
Children.
Do not use on children.
Overdose
No cases of overdose have been registered. In case of accidental overdose, dyspeptic manifestations caused by the components included in the preparation are possible.
Adverse reactions
Allergic reactions are possible, including itching, rash, urticaria, skin hyperemia and edema, and difficulty swallowing.
Expiration date
3 years.
Do not use the medicine after the expiry date stated on the packaging.
Storage conditions
Store at a temperature not exceeding 25 °C.
Keep out of reach of children.
Packaging
20 tablets in a blister; 1 blister in a cardboard box.
Vacation category
Without a prescription.
Producer
Santonica CJSC.
Location of the manufacturer and its business address.
St. Vaveryu 134B, m. Kaunas, Kaunas city Sam., LT-46353, Lithuania.
Applicant.
LLC "Materia Medica-Ukraine".
Location of the applicant.
Ukraine, 03062, Kyiv, Nyvska St., building 20, tel.: +380 (44) 400-90-78.
